A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells - He, Bailin; Wang, Qiang; Liu, Xiaoli; Lu, Ziyuan; Han, Jiaochan; Pan, Chengyun; Carter, Bing Z.; Liu, Qifa; Xu, Na; Zhou, Hongsheng (Biomedicine & pharmacotherapy, 2020)
Gesehen am 03.11.2020